Bio-Techne provides an extensive and highly sophisticated catalog of research products that serve as foundational tools for life science laboratories worldwide. Their portfolio is primarily organized around protein sciences and diagnostics, featuring high-purity recombinant proteins, antibodies, and immunoassay kits—specifically their market-leading R&D Systems brand—which are essential for detecting and quantifying proteins in biological samples. Furthermore, they manufacture advanced reagents for cell and gene therapy, including high-quality cell culture media, small molecule inhibitors, and magnetic cell separation systems. They also offer a suite of specialized analytical instruments, such as the automated Western Blotting and Simple Western systems, which revolutionize protein characterization. These tools are critical for research areas spanning immunology, cancer biology, neurobiology, and regenerative medicine, providing scientists with the precision, reliability, and reproducibility needed to push the boundaries of modern biomedical discovery from benchtop experimentation to therapeutic development.
Determining the "best" biotechnology course depends heavily on your professional goals—whether you aim for research, manufacturing, regulatory affairs, or computational biology.
The timeline to become a professional in the biotechnology field varies by the specific role.
Determining whether Bio-Techne (TECH) stock is a "good buy" depends entirely on your personal investment philosophy, your risk tolerance, and your analysis of the life sciences market.
Bio-Techne Corporation is a premier manufacturer of high-quality life science research tools, reagents, and clinical diagnostic products.
Biotechnology carries significant risks that require careful ethical and regulatory oversight.
Minneapolis and the broader Twin Cities metropolitan area constitute a significant, internationally recognized hub for medical technology and biotechnology innovation.
Biotech jobs can be highly competitive, particularly for top-tier research or specialized engineering roles at prestigious firms.
Bio-Techne Corporation is headquartered in Minneapolis, Minnesota, in the United States. This central location serves as the hub for the company’s executive leadership, strategic operations, and financial administration.
Bio-Techne operates in a highly competitive life sciences tools and clinical diagnostics market, facing rivalry from other global giants that also manufacture research reagents, proteins, and analytical instrumentation.
Yes, Bio-Techne Corporation is a large, significant player in the global life sciences industry.
Kim Kelderman serves as the Chief Executive Officer of Bio-Techne Corporation. Taking on this leadership role, he is responsible for overseeing the company's long-term strategic vision, global operations, and financial performance.
Bio-Techne’s company values are centered on driving scientific discovery through innovation, integrity, and customer-centricity.
Bio-Techne is generally perceived as a strong, stable employer within the life sciences sector, known for offering a professional work environment, competitive compensation, and a clear alignment with the mission of advancing scientific discovery.
Bio-Techne Corporation, originally founded as Techne Corporation in 1976, has a history rooted in the evolution of modern molecular biology and the demand for high-quality research tools.
The amount of math in biotechnology varies significantly depending on your role.
A career in biotechnology can be demanding and, at times, inherently stressful due to the high-stakes environment in which professionals operate.
Biotechnology is broadly categorized into four primary sectors, represented by different colors: Red, Green, White, and Blue.
Salaries in the biotechnology field are highly variable and depend on factors such as educational level, specific job function, geographic location, and company size.
Bio-Techne Corporation employs several thousand highly skilled professionals across its global operations, which include manufacturing sites, research facilities, and commercial sales offices.
The biotechnology sector is well-known for offering highly competitive compensation packages, especially for roles that require specialized technical education, such as Ph.D. holders, molecular biologists, data scientists, and process engineers.
Biotechnology is generally considered a high-paying field, particularly when compared to average national salary benchmarks in many developed nations.
Biotechnology encompasses a wide range of applications that improve human health and sustainability.
Comparing the difficulty of biotechnology and engineering is inherently subjective, as both fields are intellectually demanding but require different types of cognitive approaches.
Bio-Techne Corporation reports significant annual revenues reflecting its position as a global leader in life sciences tools and clinical diagnostics.
Bio-Techne Corporation functions as a vital supplier and technology partner to the global life sciences and pharmaceutical research communities.